Stock Earnings

Question 1

What are CASI Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), CASI Pharmaceuticals Inc has a total asset of $53, Net loss of $-39

Question 2

What are the key financial ratios for CASI?

Accepted Answer

CASI Pharmaceuticals Inc's Current ratio is 1.03, has a Net margin is -139.28, sales per share of $1.82.

Question 3

How is CASI Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

CASI Pharmaceuticals Inc largest revenue segment is Pharmaceutical Products, at a revenue of 28,537,000 in the most earnings release.For geography, China is the primary market for CASI Pharmaceuticals Inc, at a revenue of 28,537,000.

Question 4

Is CASI Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, CASI Pharmaceuticals Inc has a net loss of $-39

Question 5

Does CASI Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, CASI Pharmaceuticals Inc has liability of 51

Question 6

How many outstanding shares for CASI Pharmaceuticals Inc?

Accepted Answer

CASI Pharmaceuticals Inc has a total outstanding shares of 15.49

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	31	28	33	43	30	15
Revenue Growth (YoY)	35%	-15%	-23%	43%	100%	275%
Cost of Revenue	13	12	13	15	12	9
Gross Profit	17	15	20	27	17	5
Selling, General & Admin	45	41	41	37	38	27
Research & Development	--	8	9	15	14	11
Operating Expenses	60	50	45	53	52	38
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-43	-38	-26	-37	-35	-47
Income Tax Expense	--	0	0	1	0	--
Net Income	-46	-39	-26	-41	-36	-48
Net Income Growth	70%	50%	-37%	14%	-25%	4%
Shares Outstanding (Diluted)	16	15.34	13.36	13.64	13.61	11.04
Shares Change (YoY)	18%	15%	-2%	0%	23%	15%
EPS (Diluted)	-2.9	-2.56	-2.02	-3.01	-2.69	-4.37
EPS Growth	43%	27%	-33%	12%	-38%	-9%
Free Cash Flow	--	-29	-22	-26	-42	-45
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	54.83%	53.57%	60.6%	62.79%	56.66%	33.33%
Operating Margin	-135.48%	-121.42%	-75.75%	-60.46%	-116.66%	-220%
Profit Margin	-148.38%	-139.28%	-78.78%	-95.34%	-120%	-320%
Free Cash Flow Margin	--	-103.57%	-66.66%	-60.46%	-140%	-300%
EBITDA	--	-32	-22	-24	-34	-32
EBITDA Margin	--	-114.28%	-66.66%	-55.81%	-113.33%	-213.33%
D&A For EBITDA	--	2	3	2	1	1
EBIT	-42	-34	-25	-26	-35	-33
EBIT Margin	-135.48%	-121.42%	-75.75%	-60.46%	-116.66%	-220%
Effective Tax Rate	--	0%	0%	-2.7%	0%	--

CASI Pharmaceuticals Inc (CASI) Financial

CASI Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is CASI?

CASI Income

Follow-Up Questions